XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 275,633 $ 313,685
Marketable securities 169,613 151,687
Accounts receivable, net 96,423 104,530
Prepaid expenses and other current assets 17,418 14,878
Deferred contract costs, current 35,929 30,234
Total current assets 595,016 615,014
Property and equipment, net 6,206 7,012
Capitalized software, net 29,045 27,412
Operating lease right-of-use assets 9,849 11,377
Restricted cash, non-current 3,629 3,629
Deferred contract costs, non-current 36,510 35,411
Strategic investments 12,104 12,104
Intangible assets, net 8,264 9,331
Goodwill 12,646 12,646
Other assets 3,631 3,632
Total assets 716,900 737,568
Current liabilities:    
Accounts payable 10,792 14,529
Accrued expenses and other current liabilities 26,420 31,247
Content costs payable 35,019 37,310
Accrued compensation and benefits 27,335 22,882
Operating lease liabilities, current 6,910 7,002
Deferred revenue, current 276,050 273,937
Total current liabilities 382,526 386,907
Operating lease liabilities, non-current 4,920 6,545
Deferred revenue, non-current 4,348 4,342
Other liabilities, non-current 21 464
Total liabilities 391,815 398,258
Note 8 – Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.00001 par value - 50,000,000 shares authorized; zero shares issued and outstanding as of March 31, 2023, and December 31, 2022. 0 0
Common stock, $0.00001 par value - 950,000,000 shares authorized; 146,627,024 and 145,013,786 shares issued and outstanding as of March 31, 2023, and December 31, 2022, respectively. 1 1
Additional paid-in capital 982,128 951,946
Accumulated other comprehensive loss (96) (233)
Accumulated deficit (656,948) (612,404)
Total stockholders’ equity 325,085 339,310
Total liabilities and stockholders' equity $ 716,900 $ 737,568